Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Other Products: In Vivo | Medtech Insight | HBW Insight | Pink Sheet | Generics Bulletin

Sign In

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Existing Subscriber? Sign in to continue reading.

New to Scrip? Start a free trial today!

Email
Share

Mycenax Biotech Inc.

http://www.mycenax.com.tw

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Roche’s Actemra Scores New Indication In Rare Autoimmune Disease

Bookmark

05 Mar 2021

By Alaric DeArment

The blockbuster drug is expected to see overall sales declines in the next few years, and biosimilar competition could come as soon as 2023.

Commercial Business Strategies

See All

Company Information

Industry
Contract Research, Toxicology Testing-CRO
Contract Manufacturing Organization
Pharmaceuticals
- Generic Drugs
Biotechnology
- Large Molecule
  - Antibodies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Mycenax Biotech Inc.

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice